http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008093350-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abf1807655632ef75cf82ef95441ee39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abe27d4c769403c9b8f6952281ce52b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8957dfb4d8a325287eeddbeeed8eb5ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d6d3230077840b0e63cc07cb742ef7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459549086df37b5bed0003502de7e7aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7bd9b8f1984570e6a9ae664237a82f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1379a3d882972ff2e2b42a02df5fdf57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280024d3f2058b5839f0704d7b043de7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863fa56fc9f52a393c73d3bcde3a0a56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e154c5ac028a604ce4ed951d0a5a6b03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b540c0fae4599952f410a811bd9b69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2169b85a7a25b8a36f5f966444293240
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35aa97e1e108a63a2f28ef2bbc58b4ca
publicationDate 2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008093350-A1
titleOfInvention Novel anhydrous crystalline form of carvedilol dihydrogen phosphate
abstract The present invention provides a novel anhydrous crystalline form of carvedilol dihydrogen phosphate referred to as Form A having water content below 1.3%. Further it provides a process for the preparation of Form A. The PXRD, FT-IR and TGA data has been provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8278461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106892858-A
priorityDate 2007-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005051383-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128126843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9827459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128804889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235420902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226553103

Total number of triples: 43.